Prothena (PRTA) said Friday its board has approved a share repurchase plan of up to $100 million through Dec. 31, 2026.
The company said it plans to buy back shares from time to time through various means, subject to prevailing market conditions, corporate and regulatory limitations, and other factors and that the program can be terminated at any time.